Genomic Valley

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE574D01010
  • NSEID:
  • BSEID: 539206
INR
23.40
0.95 (4.23%)
BSENSE

Dec 22

BSE+NSE Vol: 606

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
stock-summary

Borrowings

No Borrowings in the last few periods;

stock-summary

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

stock-summary

Fixed Assets

No Fixed Assets in the last few periods;

stock-summary

Investments

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is -9.97% vs 12.79% in Mar 2024

Compare Balance Sheet Results of Genomic Valley
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.05
4.84
-1.79
-36.98%
Share Warrants & Outstandings
Total Reserve
0.84
1.67
-0.83
-49.70%
Shareholder's Funds
3.90
7.13
-3.23
-45.30%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.23
-0.23
-100.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.23
-0.23
-100.00%
Deferred Tax Assets / Liabilities
0.00
0.01
-0.01
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
0.24
-0.24
-100.00%
Current Liabilities
Trade Payables
0.01
0.28
-0.27
-96.43%
Other Current Liabilities
0.36
0.14
0.22
157.14%
Short Term Borrowings
0.00
1.19
-1.19
-100.00%
Short Term Provisions
0.09
0.00
0.09
0.00%
Total Current Liabilities
0.46
1.60
-1.14
-71.25%
Total Liabilities
4.36
8.97
-4.61
-51.39%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.01
1.47
-1.46
-99.32%
Less: Accumulated Depreciation
0.00
0.80
-0.80
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.01
0.66
-0.65
-98.48%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
1.73
0.00
1.73
0.00%
Other Non Current Assets
0.00
1.44
-1.44
-100.00%
Total Non-Current Assets
1.73
2.11
-0.38
-18.01%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.28
1.18
-0.90
-76.27%
Sundry Debtors
2.21
0.91
1.30
142.86%
Cash and Bank
0.05
0.30
-0.25
-83.33%
Other Current Assets
0.00
0.00
0.00
0.00%
Short Term Loans and Advances
0.08
4.47
-4.39
-98.21%
Total Current Assets
2.62
6.87
-4.25
-61.86%
Net Current Assets (Including Current Investments)
2.16
5.26
-3.10
-58.94%
Total Current Assets Excluding Current Investments
2.62
6.87
-4.25
-61.86%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
4.36
8.97
-4.61
-51.39%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
1.42
-1.42
-100.00%
Book Value per share (adjusted)
12.76
13.46
-0.70
-5.20%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Borrowings in the last few periods;

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets
Fixed Assets 0.01 Cr
in Mar 2025

Figures in Cr
stock-summary

No Fixed Assets in the last few periods;

Annual - Investments
Investments 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

Annual - Current Assets
Current Assets 2.62 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -9.97% vs 12.79% in Mar 2024